Literature DB >> 3452373

Missionary health: the great omission.

W R Lange1, S D Kreider, M A Kaczaniuk, F R Snyder.   

Abstract

North American mission boards were surveyed to identify and prioritize missionary medical problems and determine initiatives for improving health. Malaria was the most common nontrivial medical complaint, and viral hepatitis the most serious. Nevertheless, only 72 percent of boards recommend malaria prophylaxis, 57 percent ascribe to regular immune globulin use, and 31 percent advocate hepatitis B immunization. Sub-Saharan Africa was considered the region of the world where missionary health was most in peril. Besides strategies to minimize the risks of malaria and hepatitis, recommendations for improving missionary health include greater use of rabies and typhoid vaccines; increased attention to mental health concerns and accident prevention, particularly seat belt use; increased health education regarding both clinical issues and public health principles; improved scheduling for relaxation and family time; and greater availability of comprehensive health services before departing, while abroad, and upon returning from an overseas assignment.

Entities:  

Mesh:

Year:  1987        PMID: 3452373

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  3 in total

1.  A survey of the health of British missionaries.

Authors:  R Peppiatt; P Byass
Journal:  Br J Gen Pract       Date:  1991-04       Impact factor: 5.386

2.  Pre-travel preparation of US travelers going abroad to provide humanitarian service, Global TravEpiNet 2009-2011.

Authors:  Rhett J Stoney; Emily S Jentes; Mark J Sotir; Phyllis Kozarsky; Sowmya R Rao; Regina C LaRocque; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

3.  Illness in long-term travelers visiting GeoSentinel clinics.

Authors:  Lin H Chen; Mary E Wilson; Xiaohong Davis; Louis Loutan; Eli Schwartz; Jay Keystone; Devon Hale; Poh Lian Lim; Anne McCarthy; Effrossyni Gkrania-Klotsas; Patricia Schlagenhauf
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.